Evidence map›Paper›PMID 36439136›Full record

ArticleFrontiers in immunology2022

MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages.

Allison M Owen, Liming Luan, Katherine R Burelbach, Margaret A McBride, Cody L Stothers, Olivia A Boykin, Kalkena Sivanesam, Jessica F Schaedel, Tazeen K Patil, Jingbin Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Folinic Acid Improves Healing of Diabetic Foot Ulcers.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. IL17FMolecular medicine (Cambridge, Mass.) · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Allison M OwenDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Liming LuanDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Katherine R BurelbachDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Margaret A McBrideDepartment of Pathology, Microbiology, & Immunology, Vanderbilt University, Medical Center, Nashville, TN, United States.
Cody L StothersDepartment of Pathology, Microbiology, & Immunology, Vanderbilt University, Medical Center, Nashville, TN, United States.
Olivia A BoykinDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Kalkena SivanesamDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Jessica F SchaedelDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Tazeen K PatilDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Jingbin WangDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Antonio HernandezDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Naeem K PatilDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Julia K BohannonDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Vanderbilt University Medical Center · US

Funding

Training Innate Immunity: A new approach to the treatment of SepsisR01GM119197 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI SHERWOOD, EDWARD R, WILLIAMS, DAVID L. · 2016 to 2024
$4.6M
TIPS: Training in Perioperative ScienceT32GM108554 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire · 2014 to 2026
$3.7M
Protection Against Nosocomial Infections After Severe Burn Injury Through Trained ImmunityR35GM141927 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julia K. Bohannon · 2021 to 2026
$2.4M
Macrophage mitochodrial reprogramming and innate immune memoryR01AI151210 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHERWOOD, EDWARD R · 2020 to 2024
$2.1M
Enhancing Resistance to Infection after Burn Injury with TLR AgonistsR01GM121711 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOHANNON, JULIA K. · 2017 to 2021
$1.6M
Enhancement of Innate Anti-Microbial Immunity Using Novel Synthetic TLR4 AgonistsK08GM123345 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HERNANDEZ, ANTONIO · 2017 to 2020
$699k
XFe96 AnalyzerS10OD018015 · OD · VANDERBILT UNIVERSITY · PI LANNIGAN, DEBORAH · 2014 to 2014
$200k
NIAID NIH HHS R01 AI151210NIGMS NIH HHS K08 GM123345NIGMS NIH HHS R01 GM119197NIGMS NIH HHS R01 GM121711NIGMS NIH HHS T32 GM108554NIH HHS S10 OD018015
6 · The paper itself

Abstract

Immunocompromised populations are highly vulnerable to developing life-threatening infections. Strategies to protect patients with weak immune responses are urgently needed. Employing trained immunity, whereby innate leukocytes undergo reprogramming upon exposure to a microbial product and respond more robustly to subsequent infection, is a promising approach. Previously, we demonstrated that the TLR4 agonist monophosphoryl lipid A (MPLA) induces trained immunity and confers broad resistance to infection. TLR4 signals through both MyD88- and TRIF-dependent cascades, but the relative contribution of each pathway to induction of trained immunity is unknown. Here, we show that MPLA-induced resistance to

Indexed as

Myeloid Differentiation Factor 88Toll-Like Receptor 4Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAnimalsHumansMacrophagesMiceToll-Like ReceptorsAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportMyd88 protein, mouseMyeloid Differentiation Factor 88Toll-Like Receptor 4Toll-Like Receptorsinnate immune memoryinnate immunitymacrophagemetabolic reprogrammingMyD88TLR4toll-like receptor (TLR)trained immunity

Identifiers

PMID36439136
PMCPMC9692127
OpenAlexW4308935370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.